Reports Q3 revenue $19.46M, consensus $18.13M. “Q3 was an excellent quarter for SOPHiA GENETICS (SOPH), with revenue growth accelerating for a third consecutive quarter to 23% as new business continues to come online,” said Jurgi Camblong, PhD., CEO and Co-founder. “We also demonstrated strong operating leverage as platform scalability and rigorous cost discipline resulted in a year-over-year adjusted EBITDA loss improvement when excluding the impact of elevated Swiss social charges on equity-based compensation.”
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOPH: